NLRP3 and Myocardial fibrosis: ,28 Blockade of either NLRP3 or IL-18 additionally reduced production of chemokines that attract monocytes, lowered expression of IL-6, with blunted proinflammatory macrophage infiltration and ameliorated myocardial fibrosis.27